Ranibizumab implant (Susvimo): Formulary, Restricted to use by Devers, for adults patients with neovascular age related macular degeneration (nAMD) who have failed (or are not appropriate for) bevacizumab (Avastin) and have exhibited tolerance of and clinical response to ranibizumab injection (Lucentis).
Add Formweb to your mobile device
Ranibizumab implant (Susvimo): Formulary, Restricted to use by Devers, for adults patients with neovascular age related macular degeneration (nAMD) who have failed (or are not appropriate for) bevacizumab (Avastin) and have exhibited tolerance of and clinical response to ranibizumab injection (Lucentis).